TB Diagnostic Tests
Cross-source consensus on TB Diagnostic Tests from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Preparation
Risks & contraindications
Comparisons
Background
Highlighted claims
- Five approaches are evaluated for each participant: capillary blood CRP testing, individual Xpert MTB/RIF Ultra, pooled Xpert Ultra, lateral-flow urine LF-LAM, and digital chest X-ray with AI computer-aided detection. — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries
- Pooled sputum testing combines sputum samples from multiple individuals and tests them together using Xpert Ultra, usually in pools of four. — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries
- TB disease confirmation uses a microbiological reference standard: positive culture using the mycobacteria growth indicator tube (MGIT). — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries
- Since 2011, rapid molecular tests have transformed TB diagnosis by replacing traditional dependence on microscopy and culture in many settings. — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries
- Sputum smear microscopy remains the primary diagnostic method for more than half of the TB-affected population in high-burden countries despite newer molecular options. — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries
- WHO recommends newer molecular tests as effective, rapid, and reliable, but their high cost limits widespread use. — Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries